Features | Partner Sites | Information | LinkXpress
Sign In
FLUKE BIOMEDICAL
SCHILLER AG
Advantech Europe

2012 Best Year for Health IT Venture Capital Funding Ever

By HospiMedica International staff writers
Posted on 11 Feb 2013
Health IT venture capital (VC) funding in 2012 approached USD 1.2 billion, dwarfing the 480 million given in 2011, and the 211 million in 2010. These are the latest results reported by Mercom Capital Group (Austin, TX, USA), a healthcare information communications, and consulting firm.

The year 2012 concluded with 163 deals. The top five VC funding deals included 100 million raised by Castlight Health, which develops technology to enable comparisons of doctors, hospitals, and medical procedures based on price and quality; 58 million raised by 23andMe, a personal genetics company; 50 million raised by GoHealth, an online portal that helps compare health insurance coverage; 40 million raised by Kinnser Software, which provides clinical support to home health companies; and 34 million raised by Practice Fusion, which develops a free Web-based electronic medical record (EMR).

According to the report, the top investors that participated in VC funding rounds in 2012 were Connecticut Innovations, Founders Fund, Merck Global Health Innovation Fund, Qualcomm, and West Health Investment Fund (all with four deals each). Other notable investors included Aberdare Ventures, Canaan Partners, First Round Capital, and Khosla Ventures, with three deals apiece. In addition, although there was some overlap, slightly more funding in 2012 went towards consumer centric companies (582 million) than to companies focusing on health practice-centric technologies (591 million).

“While the focus of funding has been in the health information management category, which covers technologies on the healthcare practice side, there is significant investment and funding going into companies that engage the consumers – like mobile health, telehealth, personal health and social health,” said Raj Prabhu, managing partner of Mercom Capital Group.

Related Links:

Mercom Capital Group




Channels

Critical Care

view channel
Image: The Evzio device and trainer (Photo courtesy of kaléo).

“Rescue Pen” Averts Opioid Overdose Risk

A novel autoinjector formulation of naloxone helps reduce the problem of addiction and abuse of prescription opioids. The Evzio pen is modeled on similar devices used deliver epinephrine to patients... Read more

Women's Health

view channel

Low-Dose Aspirin Will Not Prevent Pregnancy Loss

A new study reveals that in general, low-dose aspirin is not beneficial for future pregnancy outcomes in women with prior pregnancy loss. Researchers at the University at Buffalo (NY, USA) conducted a placebo-controlled trial that included 1,228 women (aged 18-40 years) who were attempting to become pregnant.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.